National Pension Service Purchases 119,189 Shares of CVS Health Corporation $CVS

National Pension Service increased its position in CVS Health Corporation (NYSE:CVS) by 3.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,999,622 shares of the pharmacy operator’s stock after acquiring an additional 119,189 shares during the quarter. National Pension Service owned about 0.32% of CVS Health worth $301,532,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Vanguard Group Inc. grew its holdings in shares of CVS Health by 1.7% during the 2nd quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock worth $8,305,132,000 after purchasing an additional 2,063,737 shares in the last quarter. State Street Corp lifted its position in CVS Health by 1.4% in the second quarter. State Street Corp now owns 58,788,585 shares of the pharmacy operator’s stock worth $4,055,237,000 after purchasing an additional 800,414 shares during the period. Geode Capital Management LLC boosted its stake in CVS Health by 2.4% during the second quarter. Geode Capital Management LLC now owns 28,635,233 shares of the pharmacy operator’s stock worth $1,966,083,000 after buying an additional 675,824 shares in the last quarter. Invesco Ltd. boosted its stake in CVS Health by 15.3% during the second quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock worth $1,623,270,000 after buying an additional 3,118,626 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of CVS Health during the 2nd quarter valued at about $1,358,698,000. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Trading Up 0.1%

CVS stock opened at $74.51 on Friday. The business has a fifty day moving average of $78.90 and a 200-day moving average of $75.08. The company has a market cap of $94.59 billion, a P/E ratio of 196.09, a PEG ratio of 0.68 and a beta of 0.48. CVS Health Corporation has a twelve month low of $53.36 and a twelve month high of $85.15. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The firm had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. During the same period last year, the company earned $1.09 earnings per share. The company’s revenue was up 7.8% on a year-over-year basis. As a group, equities research analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd will be paid a $0.665 dividend. The ex-dividend date of this dividend is Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.6%. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

Analyst Ratings Changes

Several analysts recently commented on the company. Morgan Stanley boosted their price target on CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a research note on Wednesday, December 10th. Sanford C. Bernstein reaffirmed a “market perform” rating and issued a $91.00 target price on shares of CVS Health in a report on Tuesday, January 6th. Cantor Fitzgerald reissued an “overweight” rating on shares of CVS Health in a report on Wednesday, December 10th. Wolfe Research upped their price objective on shares of CVS Health from $85.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, December 8th. Finally, JPMorgan Chase & Co. raised their price objective on shares of CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a report on Wednesday, December 17th. Nineteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $94.82.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.